Yüklüyor......
Vaccines for the prevention against the threat of MERS-CoV
First identified in 2012, Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) is listed as a new Category C Priority Pathogen. While the high mortality of MERS-CoV infection is further intensified by potential human-to-human transmissibility, no MERS vaccines are available for human use....
Kaydedildi:
| Yayımlandı: | Expert Rev Vaccines |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5097835/ https://ncbi.nlm.nih.gov/pubmed/26985862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14760584.2016.1167603 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|